Pfizer Advances Battle Against COVID-19 on Multiple Fronts

Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...

April 10, 2020 | Friday | News
Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...

April 10, 2020 | Friday | News
I-Mab to develop TJM2 for treatment of COVID-19 related illness

I-Mab Biopharma, a clinical stage biopharmaceutical company committed to the discovery, development and commercializatio...

March 26, 2020 | Thursday | News
CytomX, Astellas to find cure for cancer

US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...

March 25, 2020 | Wednesday | News
China clears Taletrectinib IND, issues clinical trial authorizations

AnHeart Therapeutics, a clinical stage oncology company focused on underserved patients in global markets, has anno...

March 24, 2020 | Tuesday | News
Bayer, Curadev ink €250M deal for novel STING antagonists

Bayer and Curadev Pvt. Ltd., a drug discovery company based in India, on 23 March 2020 announced a research collaboratio...

March 24, 2020 | Tuesday | News
Japan approves Novartis' SMA drug

Novartis Pharma has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved Zolgensma (o...

March 19, 2020 | Thursday | News
Beijing Tide Pharma collaborates with Insilico for cancer therapy

Beijing Tide Pharmaceutical Co., Ltd. (Tide), a subsidiary of Sino Biopharmaceutical Limited, and Insilico Med...

March 18, 2020 | Wednesday | News
Japan to test AIM ImmunoTech’s Ampligen for COVID-19

AIM ImmunoTech, an immunopharmaceutical company focused on the development of immunological, viral and multiple cancer t...

March 10, 2020 | Tuesday | News
Atomwise, Bridge Bio sign $1B Deal

US based Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, and South Korea based ...

March 12, 2020 | Thursday | News
Takeda initiates development of Plasma-Derived Therapy for COVID-19

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...

March 5, 2020 | Thursday | News
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...

February 27, 2020 | Thursday | News
Arctoris launches BioTarget 2020 to support biotech company innovations

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has...

February 21, 2020 | Friday | News
Codagenix & Serum Institute to co-develop vaccine against Novel Coronavirus

Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies h...

February 14, 2020 | Friday | News
China's Borui Biomedical imitates Gilead's Coronavirus drug

Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...

February 14, 2020 | Friday | News
Gilead begins trial for coronavirus drug

US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...

February 12, 2020 | Wednesday | News
Bridge Biotherapeutics acquires new candidate for back-eye diseases

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...

February 6, 2020 | Thursday | News
Astellas submits sNDA in Japan for Evrenzo to treat Anemia

Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...

January 30, 2020 | Thursday | News